IP Library Granted Patent US 9,046,523
Granted Patent B2
US 9,046,523 · App. 13/958,335 · Granted Jun 2, 2015

Rapid bioluminescence detection system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,046,523
App. No.
13/958,335
Granted
Jun 2, 2015
Kind
B2
Abstract

An assay is provided for detecting the activity of a reporter kinase comprising (i) adding said reporter kinase to an assay mixture wherein said reporter kinase is contacted with bioluminescent reagent no more than 5 minutes after being contacted with ADP, and wherein, prior to contacting the reporter kinase with ADP, the assay mixture is substantially free from kinase other than reporter kinase; and (ii) detecting light output from the assay mixture. Methods for detecting the presence of an analyte in a sample and methods for validating a treatment process using the above assay are also provided. Further provided are devices for conducting these assays and methods.

Claims (20)

1. A lateral flow device for use in an assay for detecting the presence of a known analyte in a sample, comprising:

a backing strip on which is positioned an elongate flow matrix, wherein said flow matrix comprises:

(i) a sample-receiving zone containing an exogenous kinase attached to the flow matrix via linker comprising a binding agent specific for the analyte;

(ii) a detection zone, located downstream of the sample-receiving zone, and containing a mixture of ADP and a bioluminescent reagent; and

(iii) a background-reduction zone, situated between the sample-receiving zone and the detection zone, that substantially removes or inhibits kinase other than exogenous kinase present in the sample;

wherein, in use, a sample is applied to the sample-receiving zone and analyte present in the sample displaces exogenous kinase from the flow matrix, said displaced exogenous kinase migrates through the background-reduction zone where kinase other than exogenous kinase is substantially removed or inhibited, and then into the detection zone where ATP generation is detected.

2. The device according to claim 1 , wherein any ATP present is substantially removed from the background reduction zone.

3. The device according to claim 1 , wherein the background-reduction zone comprises one or more of a substance that substantially inhibits or removes kinase other than exogenous kinase and/or ATP.

4. The device according to claim 1 , wherein the device is portable.

5. The device according to claim 3 , wherein the one or a substance that substantially inhibits or removes kinase other than exogenous kinase and/or ATP is selected from the group consisting of an immobilised ATPase, an anionic or cationic exchange matrix, a size reduction matrix and a combination thereof.

6. A lateral flow device for use in an assay for detecting the presence of a known analyte in a sample, comprising:

a backing strip on which is positioned an elongate flow matrix, wherein said flow matrix comprises:

(i) a sample-receiving zone containing a complex comprising an exogenous kinase linked to a binding agent specific for the analyte and an analyte that is bound to said matrix;

(ii) a detection zone, located downstream of the sample-receiving zone, and containing a mixture of ADP and a bioluminescent reagent; and

(iii) a background-reduction zone, situated between the sample-receiving zone and the detection zone, that substantially removes or inhibits kinase other than exogenous kinase present in the sample;

wherein, in use, a sample is applied to the sample-receiving zone and analyte present in the sample displaces exogenous kinase from the flow matrix, said displaced exogenous kinase migrates through the background-reduction zone where kinase other than exogenous kinase is substantially removed or inhibited, and then into the detection zone where ATP generation is detected.

7. The device according to claim 6 , wherein any ATP present is substantially removed from the background reduction zone.

8. The device according to claim 6 , wherein the background-reduction zone comprises one or more of a substance that substantially inhibits or removes kinase other than exogenous kinase and/or ATP.

9. The device according to claim 6 , wherein the device is portable.

10. The device according to claim 8 , wherein the one or more of a substance that substantially inhibits or removes kinase other than exogenous kinase and/or ATP is selected from the group consisting of an immobilised ATPase, an anionic or cationic exchange matrix, a size reduction matrix and a combination thereof.

Assignments (1)
NUNC PRO TUNC ASSIGNMENT Recorded Sep 19, 2019
From: THE SECRETARY OF STATE FOR HEALTH
To: SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE
Reel/Frame 052144/0237 →